Clinical Trials for Longbio Pharma

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Longbio Pharma

Clinical Trials (7)

NCT07148557
A Study of Single Dose of LP-003 in Adolescent Subjects
PHASE1/PHASE2Not yet recruiting
6 participants
Started: Aug 31, 2025 · Completed: Sep 30, 2026
2 conditions1 sponsor0 locations
NCT06604949
A Study of Single Dose of LP-003 in Healthy Adult Subjects
PHASE1Not yet recruiting
12 participants
Started: Nov 30, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT07212426
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
PHASE2Recruiting
30 participants
Started: Nov 14, 2024 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06228560
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
PHASE2Recruiting
200 participants
Started: Jan 25, 2024 · Completed: Jan 30, 2025
1 condition1 sponsor16 locations
NCT06294301
A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants
PHASE1Recruiting
78 participants
Started: Nov 19, 2023 · Completed: Oct 30, 2024
1 condition1 sponsor1 location
NCT06294275
A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
PHASE1Active, not recruiting
68 participants
Started: Sep 16, 2022 · Completed: Apr 6, 2024
1 condition1 sponsor1 location
NCT06294288
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
PHASE1Active, not recruiting
70 participants
Started: Jul 1, 2021 · Completed: Mar 15, 2024
1 condition1 sponsor1 location